[3] Remember that managing type 2 diabetes or obesity requires a holistic approach encompassing medication, lifestyle modification, and attention to mental as well as physical wellbeing
(This story was updated to add new information) GLP-1 medications provide important safety information on their websites, including possible side effects from taking the drug
MDF and EEM provided resources
We are here to understand and support you
Molestias digestivas (las ms comunes) Nuseas: entre 20% y 44% de los pacientes (ms comn al inicio y con dosis altas) Vmitos: entre 10% y 24% Diarrea: entre 12% y 30% Estreimiento: entre 6% y 24% , segn la molcula y la duracin En general, 4 a 7 de cada 10 pacientes (40-70%) presentan algn sntoma digestivo durante el tratamiento, sobre todo en las primeras semanas, con tendencia a mejorar con el tiempo (1,8-11)
Respondents were included as having diabetes if they stated that they had ever been told by a doctor or other health professional that they had type 2 diabetes or did not know their specific type of diabetes (those with type 1 diabetes and other type of diabetes were excluded)